2012 annual workshop on the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)
Date:
22/03/2012 to 23/03/2012
Location:
European Medicines Agency, London, UK
Day one of the workshop is being organised with the assistance of The Organisation for Professionals in Regulatory Affairs and is an open meeting for all stakeholders: patient/parentorganisations, network representatives, pharmaceutical industry staff responsible for paediatric studiesand regulators. Day two on the 23 March is being attended by members of the Enpr-EMA network and the European Medicines Agency and is invitation-only.
-
List item
Agenda – Annual workshop on the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) (PDF/91.3 KB)
First published: 12/03/2012
Last updated: 12/03/2012
EMA/39173/2012 -
List item
Report on annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), 22-23 March 2012 (PDF/78.13 KB)
Adopted
First published: 11/04/2013
Last updated: 11/04/2013
EMA/218181/2013 -
List item
Presentation - Industry proposals: How to interact with and use EnprEMA (Ali Harrison, AstraZeneca) (PDF/666.65 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - The interface: Industry – CRO - Clinical trials networks (Andrew Rose, MCRN) (PDF/658.25 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Break out session 1 - Proposals on how to develop and foster new networks (Peter Helms, chair of EnprEMA CG) (PDF/241.89 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Break out session 2 - Proposals on how to encourage clinicians to participate in clinical trials Proposals on how industry can refer and use networks (Saskia de Wildt, MRRN-NL) (PDF/234.28 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Break out session 3 Proposals on how patients can be involved in networks (trial design etc) and in trials (Elizabeth Vroom, Duchene Parent Project and Juan Garcia Burgos, EMA) (PDF/240.44 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - European Network for Hyperkinetic Disorders (Dave Coghill, University of Dundee) (PDF/243.85 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - SME experience with EnprEMA (Helen Shaw, Proveca Ltd) (PDF/1.01 MB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Setting up a Young Person’s Advisory Group (Jenny Newman, MCRN) (PDF/1.5 MB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - EnprEMA (Jose Drabwell, IPOPI) (PDF/338.29 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Network's perspective - What networks can offer (Kalle Hoppu, FINPEDMED) (PDF/745.57 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - The interface between Industry – CRO and Clinical Trials Networks: Defining the roles (Martine Dehlinger-Kremer, RPS Inc. / EUCROF) (PDF/699.96 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Paediatric Rheumatology InterNational Trials Organization (Nicola Ruperto, PRINTO) (PDF/1.32 MB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - Emerging networks: Learning from successful networks (Tim Lee, European Cystic Fibrosis Society Clinical Trials Network) (PDF/733.67 KB)
First published: 12/03/2013
Last updated: 12/03/2013 -
List item
Presentation - EuroNeoNet (PDF/466.82 KB)
First published: 12/03/2013
Last updated: 12/03/2013